FDA NDC Directory · JSON-LD · Markdown

Mirabegron

NDC 70710-1160 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Labeler / ManufacturerZydus Pharmaceuticals (USA) Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA209488
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsMIRABEGRON (50 mg/1)
Marketing started20240123
Package count3

External sources

Source: openFDA. Public-domain (CC0).